LAT 15°47′ S
LON 47°52′ W
BRASIL
Brazil market read · October 2026

White mold in Brazil

What a new biological against white mold would face in Brazil. What the public data shows, and the questions an entry decision depends on.

10M+ ha
of soybean infested with white mold
€ 132M
biofungicide sales, 2024/25 (R$ 735M)
117
biological products already registered for the target

A Faperes market read. Public sources, as of 12 October 2026.

01 / 05
The problem

Fungicide protects the season. The sclerotia stay in the soil.

  • A soybean disease, in the cooler and wetter regions

    More than 10 million hectares of soybean are infested, about 28% of the planted area by an earlier estimate. Embrapa runs its white mold trials in seven states: RS, PR, MS, GO, MG, BA and DF.

    The fungus has more than 400 hosts. In Brazil it also hits dry bean (mainly irrigated), cotton, sunflower, tomato and potato.

    SourceEmbrapa Soja, Circular Técnica 189; Meyer et al. 2018, via Embrapa; Agrolink

  • Each point of incidence costs 17.2 kg of soybean per hectare

    At 20% incidence that is about 344 kg/ha, or 5.7 bags of 60 kg. In the 2021/22 trials, untreated plots reached 75% incidence and yielded about 21% less than the best treatment.

    Without management, reported losses range from 30% to 100% of yield.

    SourceEmbrapa Soja, Circular Técnica 189, citing Lehner et al. 2017; Agrolink

  • The bank of sclerotia grows season after season

    The fungus survives in the soil as sclerotia, hard dark bodies that stay viable for 4 to 10 years. In cool, humid weather they germinate, form small cups on the soil surface and release spores that infect soybean through the flowers.

    Every bad season leaves more sclerotia for the next ones. The disease is a soil problem first, and a season problem second.

    SourceEmbrapa

  • Fungicide at flowering is the backbone of control

    In Embrapa's 2021/22 cooperative trials, across 12 sites:

    TreatmentControlNote
    Dimoxystrobin + boscalid81%67% fewer sclerotia, 3,860 kg/ha, best yield
    Fluazinam + lactofen68%
    Lactofen alone42%No yield gain

    Lactofen is a herbicide used to trigger the plant's own defenses. Embrapa recommends combining fungicide, biologicals, rotation and grass straw, and states that fungicide remains necessary under high pressure.

    SourceEmbrapa Soja, Circular Técnica 189

  • Resistance is not the main pain, except in dry bean

    FRAC rates the fungus as low risk: one cycle per season and little recombination. A 2024 study of 238 Brazilian isolates, collected from 2014 to 2017 on soybean, dry bean, cotton, tomato and sunflower, found no resistance to fluazinam or procymidone.

    It found thiophanate-methyl resistance in 13 isolates, all from dry bean fields, mostly in northwest Minas Gerais, carrying the L240F mutation in beta-tubulin. Resistance management is a weak argument in soybean, and a real one in irrigated dry bean.

    SourceTropical Plant Pathology, 2024; FRAC via Syngenta Canada

  • The field is under no-till, with straw on the surface

    Over 90% of the grain area is under no-till. The recommended program combines fungicide, biologicals, rotation and uniform grass straw.

    SourceFebrapdp; Embrapa

Market read

The open gap in the Brazilian program is the soil bank. That is the space a new biological would compete for.

02 / 05
The market

The biological shelf is full, and most of it is the same organism.

  • 230 products carry Sclerotinia on the label

    113 chemical and 117 biological. The 117 biological products come from 64 different registrants. On the biological side: 83 Trichoderma (harzianum, asperellum, afroharzianum and others), 26 Bacillus (subtilis, amyloliquefaciens, velezensis, pumilus) and 8 that combine both.

    SourceAgrofit open data, MAPA, 12 Oct 2026

  • The chemical shelf is led by fluazinam and thiophanate-methyl
    ActiveProductsExamples (registrant)
    Fluazinam35Frowncide 500 SC, Altima, Agata, Legacy (ISK); Zignal (FMC); Fontico (UPL)
    Thiophanate-methyl, alone or mixed27Certeza N, Firmeza N, Exield, with fluazinam (Iharabras)
    Procymidone8Sumilex 500 WP, Sialex 500, Sumiguard 500 WP (Sumitomo)
    Boscalid, alone or mixed8Cantus; Spot SC, with dimoxystrobin (BASF)
    Iprodione4Rovral, Rovral SC (FMC)
    Fluopyram1+Attila (Bayer)
    Cyclobutrifluram, seed treatment8Victrato, Onvivis, Perzavo (Syngenta)
    Fludioxonil, alone or mixed6Maxim Advanced, Maxim Quattro, seed treatments; Switch, Fitter, with cyprodinil (Syngenta)
    Cyprodinil, alone or mixed5Unix 750 WG, Gravun, Truzon; Switch, Fitter (Syngenta)

    A product with two actives appears in both rows.

    Registrants with the most chemical products for this target: Syngenta (16), Sipcam Nichino (12), ISK (7) and Nortox (7). Most of Syngenta's 16 are seed treatments and cyprodinil-based products, outside the fungicide sprayed on soybean at flowering, where fluazinam, procymidone and boscalid lead.

    SourceAgrofit open data, MAPA, 12 Oct 2026

  • Brazilian companies hold most of the biological shelf
    RegistrantProductsBrands named in this read
    Simbiose9
    Koppert8Trichodermil, Trianum
    Total Biotecnologia7
    Biota Innovations7
    Ballagro5Ecotrich
    FMC4Romesar, Provilar
    Vittia, Bioma, Superbac3 each
    Syngenta2Taegro, Reverb
    Bayer1Serenade

    The shelf is fragmented: no registrant holds more than 9 of the 117 biological products.

    SourceAgrofit open data, MAPA, 12 Oct 2026

  • Biofungicides grew 2.4 times in three seasons
    SeasonSales (R$)Sales (€)Source
    2024/25R$ 735M€ 132MKynetec
    2023/24R$ 491M€ 88MKynetec
    2021/22R$ 306M€ 55MKynetec
    2020/21R$ 159M€ 28MSpark

    All diseases. No public source splits sales by target. Kynetec and Spark hold that split in paid reports. CropLife Brasil names white mold and rust as the drivers of the growth.

    Biofungicides are still the smallest biocontrol segment, behind bionematicides and bioinsecticides. CropLife Brasil, with a different method, puts biofungicides at R$ 1.4 billion (€ 251M) in 2025, within R$ 6.2 billion (€ 1.1 billion) of total bioinput sales. The two series should not be compared or added.

    Euro values use today's rate, R$ 5.59 per euro (12 Oct 2026), for every season.

    SourceKynetec FarmTrak; Spark BIP; CropLife Brasil

  • Trichoderma for white mold grew from 0.6M to 5M+ hectares

    0.6M ha in 2008, 1.2M ha in 2010, over 5M ha in 2015. Growers already know how to buy and use a biological against this disease.

    SourceBettiol et al. 2019, Embrapa

  • Four routes take a product to the grower
    RouteShare of crop protection salesWhat it asks of the supplier
    Distributors (revendas)45%Margin, agronomist support in the field, local proof
    Direct to large growers30%Own sales team or a partner, trials on the grower's farm
    Cooperatives25%Approval by the cooperative's technical team, regional trials
    On-farm multiplicationNot measuredA legal way for growers to skip the shelf for their own use

    Shares are for crop protection in 2017/18, the latest split by channel found in public sources. Distributors still moved 47% of all inputs reaching Brazilian growers in 2025, R$ 105 billion (€ 18.8 billion) in input sales.

    Each route sets a different price structure, partner profile and kind of proof. Large growers can buy direct and, under Law 15.070, multiply biologicals on the farm for their own use.

    SourceKleffmann, via CADE (2020); Andav and Cepea-Esalq, 11th national distribution survey (2025); Law 15.070/2024

  • Price is under pressure

    One single Trichoderma strain (T. harzianum IB 19/17) appears in 41 registered products, all approved for organic farming. That points to many companies registering the same strain through the simplified route.

    Brazil's bioinputs law (15.070/2024) also lets growers multiply biologicals on their own farm for their own use, without registration. For a large grower, the price reference for a biological can get close to the cost of multiplying it.

    SourceAgrofit open data; Law 15.070/2024

  • Credibility comes from Embrapa's cooperative trials

    In 2021/22, seven biological products were tested at up to nine sites. They cut sclerotia germination by up to 41% and raised sclerotia inviability by up to 65%, with large swings between sites.

    In the 2012/13 to 2015/16 trials, two applications worked better than one, and no yield gain was recorded. Embrapa ties results to uniform grass straw, which keeps the soil moist and cooler.

    SourceEmbrapa Soja, Circular Técnica 186; Embrapa, Trichoderma and white mold

Market read

A new Trichoderma would enter a price war. A biological with a different mode of action would stand out, and growers will ask what it adds to the Trichoderma they already use. The route it takes to the grower will shape its price as much as its efficacy.

03 / 05
The entrant

Proven in Europe is where the Brazil work starts.

  • Brazilian buyers will ask how it works on the straw

    Many European soil protocols assume the product is worked into the soil after harvest. On a no-till farm, the first questions are about surface application on straw, in soybean, in warm soils.

    A product that only works incorporated loses most of the grain area before the first trial.

    SourceFebrapdp; Embrapa

  • Registration depends on what you bring

    A strain similar to one already registered can use a simplified route. That is how one Trichoderma strain reached 41 products. A new organism, or a formula with several strains, has no similar product to lean on, and each strain needs its own assessment.

    Brazil's bioinputs law (15.070/2024) may reshape this. Its draft decree was in public consultation until 9 February 2026, and no final text had been published in the sources available in March 2026.

    SourceAgrofit open data, MAPA; KLA Advogados; Revista Cultivar

  • Evidence from abroad does not transfer

    Trials in Europe, in other crops or in pots are a starting point. Brazilian buyers will want soybean field data from the Cerrado, across states and seasons, ideally inside Embrapa's cooperative network.

    In those trials, biological results swing between sites and depend on uniform grass straw. Two applications have worked better than one.

    SourceEmbrapa Soja, Circular Técnica 186; Embrapa, Trichoderma and white mold

  • Being first only counts while nobody else files

    A new mode of action registered first sets the reference for growers, distributors and trial networks. The same organism can be owned by other companies worldwide, and any of them can file in Brazil in parallel.

    SourceAgrofit open data, MAPA

Could open
Could block
Mode of action
Could openA different mode of action can step out of the Trichoderma price war.
Could blockAnother Trichoderma has to win on price, formulation or service.
Timing
Could openThe first new organism registered sets the reference.
Could blockOthers with the same organism can file in parallel.
Market size
Could open10M+ ha infested, and biofungicides up 41% to 50% last season.
Could blockNo public split for white mold. The real prize has to be estimated.
No-till
Could openA window between soybean harvest and the next crop, on the straw.
Could blockSoil incorporation is off the table on most grain farms.
Evidence
Could openEmbrapa trials give fast credibility to those who enter them.
Could blockThe Cerrado will ask for its own trials, across states and seasons.
Price
Could openA differentiated product can price on value, not on the shelf average.
Could block41 products of one strain, plus on-farm multiplication, pull the price per hectare down.
Registration
Could openThe bioinputs law may simplify routes once its decree is final.
Could blockA new organism or a multi-strain formula has no similar product to lean on.
First crop
Could openIrrigated dry bean: high pressure, thiophanate-methyl already failing.
Could blockSmall next to soybean. Good to prove, not to scale.
Channel
Could openA fragmented shelf, with 64 biological registrants and room for partners.
Could blockNeeds a registration holder in Brazil and a channel that reaches Cerrado soybean growers.
Market read

A new biological wins in Brazil as a complement to the chemical program, lowering the sclerotia bank season after season. Brazil is the biggest prize in Latin America, and rarely the fastest.

04 / 05
Before a Brazil decision

Seven questions before bringing a biological to Brazil

  1. How big could your product be in Brazil?

    The answer depends on price per hectare, adoption and route to the grower. None of the three is public.

  2. Which country goes first?

    Brazil is the largest market. Others in Latin America may register faster.

  3. Who holds the registration?

    An own entity, a licensee or a local partner, and what that means for control of the brand.

  4. Does it work on the straw?

    Data from surface application without incorporation, and from warmer soils.

  5. What does it add to what is already on the shelf?

    A head-to-head result against Trichoderma is the argument a Brazilian grower will ask for first.

  6. Which crop proves it?

    Soybean for scale, or irrigated dry bean to prove it under high pressure.

  7. What price per hectare does it need?

    Priced against Trichoderma, or as part of the fungicide program it complements.

05 / 05
Who wrote this
Fabricio Peres
Fabricio Peres
Faperes

14 years at Syngenta, from Brazil to Latin America regional roles and global roles in Basel. His last role was Head of Sustainable and Responsible Business, Crop Protection.

Hands-on with Brazil's product registration, on submission and approval teams, as product manager and as stewardship lead.

Led the design and scale-up of one of Latin America's largest soil restoration programs, about 280,000 hectares on 400 farms.

Based in Basel, working with a network of regulatory and field specialists in Brazil.

Bringing a biological to Brazil?

Thirty minutes to test this read against your product and your data, and see what a Brazil decision would need next. Free.

Sources

More reads

Not ready to talk?

Faperes Brief. What's actually moving in Brazilian agriculture, for the people selling into it.

Subscribe on LinkedIn →